Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States

INTRODUCTION: Alopecia areata (AA), an autoimmune disease, is characterized by non-scarring hair loss involving the scalp, face, and/or body. Prior to 2022, no US Food and Drug Administration (FDA)-approved treatments for AA were available in the USA; existing treatment options had limited efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fridman, Moshe, Ray, Markqayne, Gandhi, Kavita, Shy, Morgan E., Mostaghimi, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618487/
https://www.ncbi.nlm.nih.gov/pubmed/36223027
http://dx.doi.org/10.1007/s12325-022-02338-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618487/
https://www.ncbi.nlm.nih.gov/pubmed/36223027
http://dx.doi.org/10.1007/s12325-022-02338-4

Ejemplares similares